ADM has signed an agreement with Asahi Group Foods Corporation to exclusively market and distribute Asahi Group’s proprietary lactic acid-based postbiotic, Lactobacillus gasseri CP2305. Eight human clinical trials back the postbiotic, which can target stress, mood, and sleep support. Asahi Group will continue to use the ingredient in supplements and beverages sold in Japan. Beginning in March, ADM will expand L. gasseri CP2305 distribution to food manufacturers in North America, Europe, and Asia.
